Back to Directory
research logo

Personalis, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

2/10/2026

Contact Information

πŸ‘€
Personalis, Inc.
🏒
Personalis, Inc.
πŸ“
6600 Dumbarton Circle, Fremont, California 94555, US

Industry & Market

Primary Industry
research
Location
Fremont, California, United States
Public Trading
NASDAQ: PSNL

Company Metrics

πŸ‘₯Total Employees
124
βš™οΈEngineering
38
πŸ’ΌSales Team
9
πŸ“ˆMarketing
4
πŸ“…Founded
2011
πŸ’°Revenue
84.6M

Funding Information

Market Cap
$832.1M
Annual Revenue
$84,614,000
Publicly traded company

Headcount Distribution

Total Employees
124
Departments
19

By Department

Department Breakdown

Engineering
Business Development
Operations
Sales
Accounting
Information Technology
Others

Technology Stack

Analytics & Tracking

Google AnalyticsGoogle Tag Manager

Social & Marketing

Linkedin Marketing Solutions

Email & Communication

Gmail
Total: 31 technologies

Keywords & Focus Areas

ngsimmunooncologytumor profilingtumornormal analysisimmunogenomicspersonalized cancer vaccinesimmune modulatorstumor escapetumor microenvironmenthla typingneoantigenswhole exomewhole transcriptomemachine learningneural networksmedical specialitieshealth carebiotechnology researchclinical genomic research tools+10 more
30 total keywords

Personalis, Inc.

Overview

Personalis, Inc. is a genomics company founded in 2011 and headquartered in Fremont, California. The company specializes in next-generation sequencing (NGS) technologies and molecular profiling platforms aimed at cancer genomics, population sequencing, and personalized medicine. Led by CEO John Stephen West, Personalis reported $84.6 million in revenue for fiscal year 2024.

Offering a range of services, the company delivers ultra-comprehensive genomic profiling through its proprietary NeXT platform, which analyzes up to 20,000 human genes from a single sample. Their solutions support pharmaceutical drug development, tumor profiling, and large-scale genetic researchβ€”including the Department of Veterans Affairs Million Veteran Program. Core offerings include advanced NGS tests for cancer diagnostics, rare disease diagnostics, and reproductive health, all designed to enable tailored treatments and accelerate therapeutic development.

Basic Information

Industry research
Founded 2011
Revenue $84.6M
Headquarters 6600 Dumbarton Circle, Fremont, California 94555, United States
Languages English

Contact Details

Key Focus Areas & Initiatives

  • Next-generation sequencing (NGS) technologies
  • Cancer genomics and tumor profiling
  • Population sequencing and large-scale genetic research
  • Personalized medicine and tailored treatment development
  • Reproductive and rare disease diagnostics
  • Pharmaceutical drug development support
  • Proprietary NeXT platform for comprehensive genomic profiling
  • Advanced NGS tests for diagnostics and therapeutic innovation
  • Clinical trial and sample analysis
  • Genomic data analytics and artificial intelligence
  • Healthcare and biotechnology research
  • Collaborations in cancer research and genomics

Technologies Used

  • AI
  • Act!
  • Atlassian Cloud
  • CloudFlare Hosting
  • Cloudflare DNS
  • Enom
  • Gem
  • Git
  • Gmail
  • Google Analytics
  • Google Apps
  • Google Font API
  • Google Tag Manager
  • LabWare LIMS
  • Linkedin Marketing Solutions
  • Liquid
  • Micro
  • Microsoft Excel
  • Mist
  • Mobile Friendly
  • Ning
  • Oracle Cloud
  • Pantheon
  • Pardot
  • Remote
  • Salesforce
  • Slack
  • Typekit
  • WP Engine
  • Webmail
  • WordPress.org

Affiliated Organizations & Regional Branches

    Need more information?

    Find decision makers, more insights and contact information about this company on Bitscale

    Start For Free

    Schedule your demo now!

    See how BitScale can supercharge your outbound sales in a 30-minute demo

    Start for Free

    Resources

    Careers

    Pricing

    homeCommunity

    Security

    SayData

    Β© 2026 Bitscale. Featherflow Technology Pvt Ltd.

    LinkedInTwitterInstagramYouTube
    AICPAGDPR
    CCPAISO
    LinkedInTwitterInstagramYouTube